QUB to help conduct rapid COVID-19 testing trial

  • Queen’s University Belfast (QUB) is aiming to develop a rapid diagnostic test for COVID-19 that will show results within an hour.

    The test would enable health professionals to test for COVID-19 on site, eliminating the need to send tests to a centralised laboratory, saving time and resources.

    The university received funding of €930,000 for the trial along with a partnership of medtechs; HiberGene Diagnostics Ltd, Medcaptain in China, and Italian Hospital IRCCS Ospedale Policlinico San Martino.

    Professor Cliff Taggart, lead medical researcher at QUB said: “The local availability, speed and accuracy of the test will help inform public health preparedness and response in the ongoing pandemic.”

    RELATED: Ulster University Professors join COVID-19 antibody test consortium

    The Belfast Health and Social Care Trust (HSC) carried out the initial development work on a prototype Meningococcal Disease test in collaboration with QUB.

    This meningitis test has since been licensed and issued to over 70 countries via Hibergene’s network of 45 distributors.

    CEO of Hibergene, Seamus Gorman said: “We are delighted to lead an international consortium to quickly develop and bring to market a rapid easy to use molecular diagnostic test for COVID 19 disease.”

    RELATED: QUB need public's help in study to identify COVID-19 highest risk factors

    Source: Written from press release

    About the author

    An article that is attributed to Sync NI Team has either involved multiple authors, written by a contributor or the main body of content is from a press release.

    Got a news-related tip you’d like to see covered on Sync NI? Email the editorial team for our consideration.

Share this story